Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1983-7-8
pubmed:abstractText
The minimal inhibitory concentrations of nine antimicrobial agents was determined for over 750 clinical isolates of the Bacteroides fragilis group of anaerobic bacteria collected from nine centers in the United States during 1981. High resistance rates were documented for cefoperazone, cefotaxime, and tetracycline. Cefoxitin had the best activity of the beta-lactam antibiotics, whereas moxalactam and piperacillin had good activities. The resistance rate for clindamycin was 6%. There were no metronidazole- or chloramphenicol-resistant isolates encountered. There were significant differences in susceptibility among the various species of the B. fragilis group, particularly with moxalactam, cefoxitin, and clindamycin. Clustering of clindamycin-, piperacillin-, and cefoxitin-resistant isolates was observed at different hospitals. The variability of resistance rates with the beta-lactam antibiotics and clindamycin indicates that susceptibility testing of significant clinical isolates should be performed to define local resistance patterns.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-232936, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-28690, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-4335792, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-4680804, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-553477, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-6214986, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-6267427, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-690032, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-6966626, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-6983857, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7012991, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7040329, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-708014, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7305321, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7325628, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7338488, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-7997, http://linkedlifedata.com/resource/pubmed/commentcorrection/6859833-856019
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
536-40
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Susceptibility of the Bacteroides fragilis group in the United States in 1981.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.